Re: Clinical trials for Circulating Tumor Cells
What about after tx,Surely ctc/Lgg levels should be monitored to give some idea as to whether there are active tumour burdens and so that treatment can be restarted before the tumour starts to become a problem that cannot be eradicated?
|